BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31822720)

  • 1. Metformin activates KDM2A to reduce rRNA transcription and cell proliferation by dual regulation of AMPK activity and intracellular succinate level.
    Tanaka Y; Konishi A; Obinata H; Tsuneoka M
    Sci Rep; 2019 Dec; 9(1):18694. PubMed ID: 31822720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of ROS by Gallic Acid Activates KDM2A to Reduce rRNA Transcription.
    Tanaka Y; Obinata H; Konishi A; Yamagiwa N; Tsuneoka M
    Cells; 2020 Oct; 9(10):. PubMed ID: 33050392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild Glucose Starvation Induces KDM2A-Mediated H3K36me2 Demethylation through AMPK To Reduce rRNA Transcription and Cell Proliferation.
    Tanaka Y; Yano H; Ogasawara S; Yoshioka S; Imamura H; Okamoto K; Tsuneoka M
    Mol Cell Biol; 2015 Dec; 35(24):4170-84. PubMed ID: 26416883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CxxC-ZF domain is needed for KDM2A to demethylate histone in rDNA promoter in response to starvation.
    Tanaka Y; Umata T; Okamoto K; Obuse C; Tsuneoka M
    Cell Struct Funct; 2014; 39(1):79-92. PubMed ID: 24553073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JmjC enzyme KDM2A is a regulator of rRNA transcription in response to starvation.
    Tanaka Y; Okamoto K; Teye K; Umata T; Yamagiwa N; Suto Y; Zhang Y; Tsuneoka M
    EMBO J; 2010 May; 29(9):1510-22. PubMed ID: 20379134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallic Acid Derivatives Propyl Gallate and Epigallocatechin Gallate Reduce rRNA Transcription via Induction of KDM2A Activation.
    Tanaka Y; Tsuneoka M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A CxxC domain that binds to unmethylated CpG is required for KDM2A to control rDNA transcription].
    Tsuneoka M; Tanaka Y; Okamoto K
    Yakugaku Zasshi; 2015; 135(1):11-21. PubMed ID: 25743893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of histone demethylase KDM2A inhibited cell proliferation of stem cells from apical papilla by de-repression of p15INK4B and p27Kip1.
    Gao R; Dong R; Du J; Ma P; Wang S; Fan Z
    Mol Cell Biochem; 2013 Jul; 379(1-2):115-22. PubMed ID: 23559091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells.
    Dhar SS; Alam H; Li N; Wagner KW; Chung J; Ahn YW; Lee MG
    J Biol Chem; 2014 Mar; 289(11):7483-96. PubMed ID: 24482232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammalian lysine histone demethylase KDM2A regulates E2F1-mediated gene transcription in breast cancer cells.
    Rizwani W; Schaal C; Kunigal S; Coppola D; Chellappan S
    PLoS One; 2014; 9(7):e100888. PubMed ID: 25029110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.
    Liu H; Liu L; Holowatyj A; Jiang Y; Yang ZQ
    Mol Carcinog; 2016 May; 55(5):977-90. PubMed ID: 26207617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone demethylase KDM2A suppresses EGF-TSPAN8 pathway to inhibit breast cancer cell migration and invasion in vitro.
    Zhang H; Tu Y; Huang B; Xiao J; Xiao J; Wang J; Pei Y; Yang R; Feng J; Li J; Zhang X
    Biochem Biophys Res Commun; 2022 Nov; 628():104-109. PubMed ID: 36084547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAcylation of fumarase maintains tumour growth under glucose deficiency.
    Wang T; Yu Q; Li J; Hu B; Zhao Q; Ma C; Huang W; Zhuo L; Fang H; Liao L; Eugene Chin Y; Jiang Y
    Nat Cell Biol; 2017 Jul; 19(7):833-843. PubMed ID: 28628081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling.
    Wagner KW; Alam H; Dhar SS; Giri U; Li N; Wei Y; Giri D; Cascone T; Kim JH; Ye Y; Multani AS; Chan CH; Erez B; Saigal B; Chung J; Lin HK; Wu X; Hung MC; Heymach JV; Lee MG
    J Clin Invest; 2013 Dec; 123(12):5231-46. PubMed ID: 24200691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine demethylase 2A promotes stemness and angiogenesis of breast cancer by upregulating Jagged1.
    Chen JY; Li CF; Chu PY; Lai YS; Chen CH; Jiang SS; Hou MF; Hung WC
    Oncotarget; 2016 May; 7(19):27689-710. PubMed ID: 27029061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative isoforms of KDM2A and KDM2B lysine demethylases negatively regulate canonical Wnt signaling.
    Lađinović D; Pinkas D; Šopin T; Raška O; Liška F; Raška I; Vacík T
    PLoS One; 2020; 15(10):e0236612. PubMed ID: 33104714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3.
    Lu B; Wei J; Zhou H; Chen J; Li Y; Ye L; Zhao W; Wu S
    Cell Death Dis; 2022 Jun; 13(6):547. PubMed ID: 35697678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of AMP-activated protein kinase in mechanism of metformin action.
    Zhou G; Myers R; Li Y; Chen Y; Shen X; Fenyk-Melody J; Wu M; Ventre J; Doebber T; Fujii N; Musi N; Hirshman MF; Goodyear LJ; Moller DE
    J Clin Invest; 2001 Oct; 108(8):1167-74. PubMed ID: 11602624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.
    Banerjee P; Surendran H; Chowdhury DR; Prabhakar K; Pal R
    J Mol Med (Berl); 2016 Dec; 94(12):1397-1409. PubMed ID: 27534967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.